Kevin C. Flanagan

机构：Cofactor Genomics (United States) · ORCID：0009-0005-3364-1677

发表论文 67 篇 · 总被引 1278 次 · h-index 14

代表论文

Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss (2018 · Cancer Research · 被引 68)
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells (2022 · Clinical Cancer Research · 被引 48)
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes (2021 · Journal for ImmunoTherapy of Cancer · 被引 45)
T cell subtype profiling measures exhaustion and predicts anti-PD-1 response (2022 · Scientific Reports · 被引 22)
HD-EPIC: A Highly-Detailed Egocentric Video Dataset (2025 · 被引 19)
Analytical Performance of an Immunoprofiling Assay Based on RNA Models (2020 · Journal of Molecular Diagnostics · 被引 15)